Panday, V R <br/><br/>
Pharmacologic study of 3-hour 135 mg M-2 paclitaxel in platinum pretreated patients with advanced ovarian cancer.  [electronic resource] 

 -  Pharmacological research  Sep 1998 
 - 231-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1043-6618 
<br/><br/><label>Standard No.: </label>10.1006/phrs.1998.0360  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Female<br/>Humans<br/>Middle Aged<br/>Organoplatinum Compounds--therapeutic use<br/>Ovarian Neoplasms--drug therapy<br/>Paclitaxel--administration & dosage